Atlas Trials

Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay

Clinical trial NCT05643690 · SUSPENDED

Trial details

NCT number
NCT05643690
Sponsor
AnchorDx Medical Co. Ltd. US
Status
SUSPENDED
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2022-11-18
Primary completion
2025-12-31
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.